Thyrotrophin-releasing hormone-induced growth hormone secretion in domestic fowl: concomitant stimulation of dopamine turnover in the medial basal hypothalamus.
Thyrotrophin-releasing hormone (TRH) stimulates GH secretion in domestic fowl by actions at pituitary and central nervous system sites. The possibility that this central action might be mediated by hypothalamic catecholamines or indoleamines was therefore investigated. When TRH was administered into the lateral ventricles of anaesthetized fowl the concentration of 3,4-dihydroxyphenylacetic acid (DOPAC, a metabolite of dopamine (DA)) in the medial basal hypothalamus (MBH) was increased within 20 min. The concentrations of MBH noradrenaline (NA), DA, serotonin (5-HT) and 5-hydroxyindoleacetic acid (5-HIAA) were, however, unaffected by the intra-cerebroventricular (i.c.v.) administration of TRH, although the MBH concentrations of somatostatin and TRH were concomitantly reduced. A rapid increase in DA release into MBH extracellular fluid and its metabolism to DOPAC was also observed after i.c.v. or i.v. administration of TRH, in birds in which the MBH was perfused in vivo with Ringer's solution. Microdialysate concentrations of NA, 5-HT and 5-HIAA were not, however, affected by central or peripheral injections of TRH. Diminished GH responses to i.v. TRH challenge occurred in birds pretreated with reserpine (a catecholamine depletor), alpha-methyl-paratyrosine (a DA synthesis inhibitor) and pimozide (a DA receptor antagonist). These results therefore provide evidence for the involvement of a hypothalamic dopaminergic pathway in the induction of GH release following the central or peripheral administration of TRH. In contrast with its inhibitory actions at peripheral sites, DA would appear to have a central stimulatory role in regulating GH release in birds.
Harvey
S
S
Department of Physiology, University of Alberta, Edmonton, Canada.
Lea
R W
RW
D000588:Amines / Q000378:metabolism; D000818:Animals; D002645:Chickens / Q000378:metabolism*; D004298:Dopamine / Q000378:metabolism*; D013006:Growth Hormone / Q000378:metabolism*; D007033:Hypothalamus, Middle / Q000187:drug effects / Q000378:metabolism*; D007276:Injections, Intraventricular; D008781:Methyltyrosines / Q000494:pharmacology; D010455:Peptides / Q000378:metabolism; D010868:Pimozide / Q000494:pharmacology; D012110:Reserpine / Q000494:pharmacology; D013973:Thyrotropin-Releasing Hormone / Q000494:pharmacology*; D019805:alpha-Methyltyrosine
D000588:Amines; D008781:Methyltyrosines; D010455:Peptides; D010868:Pimozide; D013973:Thyrotropin-Releasing Hormone; D019805:alpha-Methyltyrosine; D012110:Reserpine; D013006:Growth Hormone; D004298:Dopamine